A 31 amino acid fragment of HMGN2 protein identified by Ruoslahti's group using in vivo phage display techniques, has been shown to bind to tumor and endothelial cells in tumor blood vessels. Reagent-grade; for laboratory research purposes only.
Usually ships within 24 hours.